6 Most Important Things in Business Today
The FCC has killed net neutrality, Disney has become the king of all media, holiday spending has been unusually strong, and more important headlines.
The FCC has killed net neutrality, Disney has become the king of all media, holiday spending has been unusually strong, and more important headlines.
Teva Pharmaceutical Industries shares turned south on Wednesday after the company said that it would be announcing its restructuring plan on Thursday.
The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
A generic version of Viagra is coming to America, but will existing customers be willing to switch over to a generic version of the pill?
The top analyst upgrades, downgrades and other research calls from Monday include Best Buy, Equifax, Gilead Sciences, MongoDB, NVIDIA, Rio Tinto, Teva Pharmaceutical and UPS.
The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Teva, General Electric, Newell Brands, and Oclaro all posted new 52-week lows Thursday.
These quarterly numbers are another black eye for Teva Pharmaceutical, sending shares to a low not seen since 2002.
The October 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Among the most shorted stocks traded on the New York Stock Exchange, two struggling retailers saw notable growth in their short interest in the latest reporting period.
PG&E, Teva Pharmaceuticals, Vipshop, and 3D Systems all posted new 52-week lows Friday.
General Electric, Rite Aid, J.C. Penney, and Teva all posted new 52-week lows with high volume on Thursday.
The September 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The September 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The top analyst upgrades, downgrades and other research calls from Monday include ASML, General Electric, HubSpot, Infosys, Teva Pharmaceutical and United Continental.